☰

TermoSalud

Updating the operating model

Industry
Biotechnology
Public information as of
January 2026

A4BEE prepared this analysis from publicly available sources. It reflects our own reading of TermoSalud's published strategy and is not endorsed by, or produced in cooperation with, TermoSalud. Company website

Strategic priorities

TermoSalud operates across 4 stated priorities, with the most concrete near-term plan anchored on us market penetration.

Establish sustainable commercial foothold in USA through FDA 510(k) clearances (Zionic Aesthetic, Eneka Selectif, Zionic Pro Max) and presence at AAD Annual Meeting, targeting data-driven American clinic chains.

Execute IDEPA-funded projects including intelligent ERP implementation and advanced electronic device manufacturing modernization to scale production capacity for US demand surge.

Advance AGENIA (anti-aging cellular therapy) and DERMALighT (molecular light therapy) research projects from laboratory to market, positioning beyond hardware into biotech-adjacent spaces.

Challenges we see

  • Operations Manufacturing

    Manufacturing Scalability Bottleneck

    TermoSalud's "100% Spanish manufacturing" model from the Gijon facility faces severe stress scaling for US market demand following 2024/2025 FDA clearances. Manual assembly processes for complex devices like Eneka PRO (high-voltage power supplies, laser diode stacks, cooling compressors) cannot rapidly increase throughput.

    Without MES or automated quality control, increasing production speed leads to quality fade or bottlenecking at manual step testing stations, threatening FDA-mandated Device History Record compliance and the brand reputation built over 30 years.

  • Operations Operations

    Supply Chain Opacity & Inventory Volatility

    Financial data reveals bullwhip effect with revenue contracting -2.71% in 2023 followed by 19.03% surge in 2024, indicating reactive supply chain management without predictive capabilities for component lead times (chips, laser diodes).

    The 2024 demand surge likely caused massive strain on inventory levels, potentially leading to stockouts or expensive expedited shipping, with long component lead times threatening ability to fulfill US orders on time.

  • Digital Integration

    Disconnected Device Ecosystem

    TermoSalud devices are air-gapped islands with LCD touch screens and USB ports but no Wi-Fi, Ethernet, or Cloud connectivity. Competitors Lumenis offer "Smart Clinic" cloud platforms while Indiba provides Wi-Fi-enabled "Activ CT9" with monitoring software.

    TermoSalud cannot offer usage-based billing, fleet management, or patient data analytics to US clinic owners. Selling "dumb" devices to data-driven corporate clinic chains becomes increasingly difficult regardless of clinical efficacy.

  • Compliance Regulatory

    FDA Post-Market Surveillance Gap

    With three recent 510(k) clearances, TermoSalud is subject to 21 CFR Part 803 (Medical Device Reporting) and Part 820 (Quality Systems). FDA requires active monitoring for adverse events with recent warnings about RF microneedling risks heightening urgency.

    Without digital telemetry, reliance on patients or clinics to report adverse events creates a laggy, risky process. If a Zionic device causes an incident in California, Gijon may only learn through delayed warranty claims rather than immediate automated alerts.

  • Digital Integration

    IT/OT Integration Failure Risk

    TermoSalud received IDEPA grant for "Intelligent ERP Implementation" but such implementations in manufacturing SMEs notoriously fail at the "Last Mile" - connecting office ERP to factory floor operations that run on paper travelers and whiteboards.

    The ERP investment may sit disconnected from production reality, delivering less of the promised operational intelligence than intended.

Opportunities, by urgency and business impact

Each bubble is one opportunity, numbered to match the list below. Further right means it bites sooner; higher means a bigger effect on the business. A bigger bubble means a bigger implementation effort.

Source: A4BEE analysis of public sources

  1. Real-Time Production Visibility Gap

    The Gijon factory lacks a Manufacturing Execution System connecting production floor to ERP. Quality assurance relies on manual testing stations without automated pass/fail logging, making it impossible to simulate bottlenecks before physical expansion or maintain FDA-required Device History Records digitally.

    Deploy Industry 4.0 Digital Twin of production line with OT sensors on testing benches to automate quality logging. Connect the new "Intelligent ERP" to actual machines (PLCs, CNCs, Assembly Stations) ensuring the granted investment delivers real intelligence to production.

  2. Blind Distributor Service Network

    TermoSalud's main objective is "offering an after-sales service that guarantees maximum satisfaction" but they rely on third parties like Cosmeditech (UK) and Healthspan (Philippines). HQ is blind when devices fail globally - only finding out when warranty parts are ordered. Technicians often replace expensive components when simple software resets might suffice.

    Retrofit devices with IoT telemetry allowing Gijon support team to see error codes remotely. Build "TermoSalud Service Cloud" enabling HQ to triage issues before dispatching partner technicians, reducing Time-to-Resolution and warranty costs across 45+ export countries.

  3. Competitive Digital Feature Deficit

    Zionic and Eneka PRO manuals mention LCD touch screens and USB ports but no Wi-Fi, Ethernet, or Cloud connectivity. The Zionic Pro Max "Virtual Assistant" appears local rather than cloud-connected. Lumenis offers "Smart Clinic" live business intelligence while Indiba surrounds their 448 kHz frequency with digital ecosystem.

    Design IoT architecture to transform Zionic/Symmed into connected devices. Build middleware securely extracting treatment data to cloud dashboard, enabling usage-based billing, fleet management, and patient analytics that US corporate clinic chains expect.

  4. Regulatory Compliance Automation Need

    FDA mandates UDI (Unique Device Identification) tracking and post-market surveillance. TermoSalud's software is now under FDA scrutiny (IEC 62304) per 2025 Zionic Pro Max clearance stating "software-powered user interface." Tracking spare parts and handpieces across decentralized distributor network using spreadsheets is compliance liability.

    Implement automated regulatory compliance using IoT data to log treatment parameters (Power, Time, Temperature). System flags treatments exceeding safety limits immediately. Digital audit trail with blockchain/digital ledger ensures traceability of every serial number containing specific component batches.

  5. R&D Data Silos in Biotech Projects

    AGENIA (anti-aging cellular therapy) and DERMALighT (molecular light therapy) projects involve complex longitudinal data sets (cellular aging markers, molecular regeneration data) likely managed in Excel or isolated desktop software. Disparate R&D domains lack unified Laboratory Information Management System preventing insight cross-pollination.

    Implement Electronic Lab Notebook (ELN) and data analytics platform for R&D department. Accelerate Time-to-Insight for publishing clinical papers faster - a critical marketing tool in medical aesthetics industry where clinical evidence differentiates premium devices.

What we'd propose

  • Digital CDMO

    Smart Factory Production Intelligence Platform

    Deploy comprehensive Industry 4.0 infrastructure connecting Gijon manufacturing floor to the new Intelligent ERP, automating quality logging and enabling Digital Twin simulation for production scaling to meet US demand.

    • OT/IT convergence

      Pull sensor and controller data off the line into a shared data plane in real time.

      DETAIL

    • Batch intelligence

      Golden-batch comparison and deviation detection running on the same data plane.

      DETAIL

    • Production release flow

      Closed-loop between QA, MES, and ERP so batch record review and release follow the data, not the paperwork.

      DETAIL

    • Shorter lead time from data capture to decision.
    • Records that audit on their own, not on inspection day.
    • Scale without adding the same headcount.

    We've done this before

    See how we do Digital CDMO
  • Digital Lab

    Connected Device IoT Architecture

    Design and implement the connectivity layer transforming Zionic, Eneka, and Symmed devices from air-gapped hardware into cloud-connected intelligent platforms competing with Lumenis Smart Clinic capabilities.

    • Unified data backbone

      Connect instruments and LIMS into a single data spine so QC and CDMO records are queryable across sites.

      DETAIL

    • Paperless workflows

      Move lab execution from paper to instrument-captured records with full audit trail.

      DETAIL

    • Continuous QC release

      Review-by-exception dashboards that flag only the records needing scientist attention.

      DETAIL

    • Shorter lead time from data capture to decision.
    • Records that audit on their own, not on inspection day.
    • Scale without adding the same headcount.

    We've done this before

    See how we do Digital Lab
  • Digital CDMO

    Remote Diagnostics & Service Cloud

    Build centralized service platform enabling Gijon headquarters to remotely diagnose, triage, and resolve device issues across the global distributor network, transforming reactive break-fix into proactive support.

    • OT/IT convergence

      Pull sensor and controller data off the line into a shared data plane in real time.

      DETAIL

    • Batch intelligence

      Golden-batch comparison and deviation detection running on the same data plane.

      DETAIL

    • Production release flow

      Closed-loop between QA, MES, and ERP so batch record review and release follow the data, not the paperwork.

      DETAIL

    • Shorter lead time from data capture to decision.
    • Records that audit on their own, not on inspection day.
    • Scale without adding the same headcount.

    We've done this before

    See how we do Digital CDMO
  • Digital Lab

    FDA Digital Compliance Twin

    Implement automated regulatory compliance infrastructure that digitally captures, validates, and reports device performance data meeting FDA 21 CFR Part 803/820 requirements and UDI traceability mandates.

    • Unified data backbone

      Connect instruments and LIMS into a single data spine so QC and CDMO records are queryable across sites.

      DETAIL

    • Paperless workflows

      Move lab execution from paper to instrument-captured records with full audit trail.

      DETAIL

    • Continuous QC release

      Review-by-exception dashboards that flag only the records needing scientist attention.

      DETAIL

    • Shorter lead time from data capture to decision.
    • Records that audit on their own, not on inspection day.
    • Scale without adding the same headcount.

    We've done this before

    See how we do Digital Lab
  • Digital Lab

    Lab 4.0 R&D Digitalization

    Transform AGENIA and DERMALighT research programs with unified digital infrastructure, implementing Electronic Lab Notebook and analytics platform to accelerate clinical evidence generation for market differentiation.

    • Unified data backbone

      Connect instruments and LIMS into a single data spine so QC and CDMO records are queryable across sites.

      DETAIL

    • Paperless workflows

      Move lab execution from paper to instrument-captured records with full audit trail.

      DETAIL

    • Continuous QC release

      Review-by-exception dashboards that flag only the records needing scientist attention.

      DETAIL

    • Shorter lead time from data capture to decision.
    • Records that audit on their own, not on inspection day.
    • Scale without adding the same headcount.

    We've done this before

    See how we do Digital Lab

Digital maturity: today and target

Scored out of 100 across six dimensions. The target is what TermoSalud's own published ambition implies — not a perfect score.

Source: A4BEE analysis of public sources
Manufacturing Digitalization 35 → 75
Manual assembly processes with grant request acknowledging need for "technological advice on manufacturing of advanced electronic devices"; no MES connecting floor to ERP
Product Connectivity 15 → 80
Devices air-gapped with USB only; no Wi-Fi/Ethernet/Cloud; competitors Lumenis and Indiba offer full cloud ecosystems with business intelligence
Service & Support Digitalization 25 → 70
Reactive break-fix model via distributed partners; HQ blind to device performance; no remote diagnostics or predictive maintenance
Regulatory Technology 30 → 75
Software now under FDA IEC 62304 scrutiny; UDI tracking via spreadsheets across distributor network; manual post-market surveillance process
R&D Data Infrastructure 30 → 70
AGENIA and DERMALighT data likely in Excel/desktop software; no unified LIMS; multiple research domains operate in silos
IT/OT Integration 25 → 70
IDEPA-funded Intelligent ERP implementation at risk of "Last Mile" failure; grant-funded pilots potentially incomplete; factory floor disconnected from office systems

Check this yourself

Our Service Portal has free self-assessments and market comparisons. These are the ones that line up with what we've read above — no sales call required.

Think we've read this right?

Talk to us

Related reading

This is an independent analysis prepared by A4BEE from publicly available information as of January 2026. It reflects A4BEE's own interpretation and opinion, is not affiliated with, endorsed by, or verified with TermoSalud, and may be incomplete or inaccurate. All company names and trademarks are the property of their respective owners. To request a correction or removal, contact [email protected].